Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Clinical trial NCT01766739 · COMPLETED
Trial details
- NCT number
- NCT01766739
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2024-10-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.